Thyrocare Technologies Limited announced that its Board of Directors, in a meeting held on January 28, 2026, approved an amendment to the Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives. The amended code has been made available on the company's website and will also be submitted to the National Stock Exchange of India Limited and BSE Limited. The amendment pertains to the company's compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The detailed code outlines definitions, responsibilities of the Compliance Officer, preservation of Unpublished Price Sensitive Information (UPSI), prevention of misuse of UPSI, trading plans, reporting requirements, and trading window and pre-clearance of trades. It also specifies procedures for initial and continual disclosures by designated persons, promoters, and other connected persons. The code emphasizes the need for a 'need to know' basis for sharing UPSI and the establishment of a Structured Digital Database (SDD) for tracking information dissemination.
